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Intelligent Wound Dressing for 
Wound Infection Management and 
Diagnosis at Point of Care
Abstract
Here we present the development of a prototype wound dressing that can detect
the infection in wounds. The dressing is made of a hydrated agarose sheet in
which a mixture of fluorescent dye containing vesicles and agarose are dispersed
within the hydrogel matrix. The release of dye is triggered by the interaction of
vesicles with virulence factors, secreted within the biofilms via population-density-
dependent quorum sensing, from clinical pathogens of Staphylococcus aureus,
Pseudomonas aeruginosa and Enterococcus faecalis (SPE pathogen group). The
dressing only activates when in contact with wound biofilm of pathogenic bacteria
in infected wounds, but not to the biofilms of non-pathogenic bacteria.
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Introduction
Wound infection is a global problem and approximately 13,000 patients with burns
require treatment in hospitals in England and Wales every year.1,2 Burn wound
infection is currently diagnosed by clinical observation and judgement, and
standard microbiological culture to identify causative pathogens usually take
several days.3,4 There are evidences that the delayed healing due to persistent
infection is closely related to wound biofilm formation.5,6 If pathogens present, this
will cause tissue damage by further colonization, extensive infection and formation
of difficult-to-treat biofilm in wounds which inevitably require aggressive antibiotic
treatments.7 Early indication of infection at point of care and ability to rapidly
distinguish between infected and non-infected states of wound will help in clinical
decision making, prevent over-management by inappropriate use of antibiotics,
improve patient outcomes and reduce costs of treatment.
Methods, Results and Discussion
1) Vesicles and Mode of Action of Detection
Vesicles of 200 nm in diameter were made of 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC), cholesterol and 10,12-tricosadiyonic acid (TCDA) by
extrusion.8 Encapsulated inside vesicles were 50 mmol dm-3 self-quenched 5,6-
carboxyfluorescein in HEPES buffer. Only exotoxins of pathogenic bacteria, such
as Phenol-Soluble Modulin (PSM), delta haemolysin and rhamnolipids lysed
vesicles and triggered the release of visible dyes (figure 1).9,10 Expression of such
virulence factors by wound pathogens such as S. aureus and P. aeruginosa was
demonstrated by growing them on the blood agar plate (figure 2).
3) Clinical Assessment of Prevalent Burn Wound Pathogens
An independent assessment of 55 burn wounds at Queen Victoria Hospital (QVH)
at East Grinstead, U.K. provided that more than 75% of “at risk” wounds were
colonized by species of pathogenic bacteria, of which above 80% were identified
as S. aureus, P. aeruginosa and E. faecalis strains (SPE pathogens) (figure 4)
Figure 1. Schematic depiction of mode of action of vesicles 
against pathogenic bacteria. (a) Pathogens produce toxins that 
can lyse lipid bilayer membrane of vesicles, and (b) trigger the 
release of dye which is visible to naked eye.
Figure 2. Exotoxins, such as PSM, delta haemolysin 
and rhamnolipids of pathogenic S. aureus and P. 
aeruginosa lyse erythrocytes in blood agar to release 
haemoglobin (seen as halo), but not by control 
Escherichia coli.
2) Dressing Design and Prototype Development
The vesicles were mixed with molten 0.7% agarose and filled inside the patterned
wells of moulded 2% agarose dressing (figure 3a,b).11 This design allows the
diffusion of toxins from infected wound to the dressing, following the fluorescent
dyes release from vesicles within hydrogel matrices (figure 3c).
Figure 3. Prototype dressing development (a) Embossed mould is used to make a thin slab of agarose with patterned wells, which 
are filled with vesicles + agarose, (b) finished prototype, and (c) before and after the activation of dressing with Triton on an arm.
Figure 4. Clinical assessment study of prevalent burn wound pathogens (a) 73% of infected wounds are colonized by pathogenic 
bacteria while (b) 83% of them are  identified S. aureus, P. aeruginosa and E. faecalis with majority of S. aureus colonisation.
4) In-vitro Colony Wound Biofilm Model
For the evaluation on prototype dressing performance, a model wound biofilm was
developed by growing biofilms on a nano-porous polycarbonate membrane (200
nm in diameter) on top of nutrient agar, incubated at 37°C (figure 5a,b).12 Growth
of biofilm was characterized by Scanning Electron Microscope (figure 5c).
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Figure 5. In-vitro colony wound biofilm model (a) schematic depiction of growth of a biofilm by acquiring nutrients through nano-
pores, (b) photograph of S. aureus biofilms on polycarbonate membranes, and (c) SEM images of biofilms of E. coli and selected 
SPE strains (black arrows indicate the characteristic extracellular polymeric substances (EPS) of a biofilm).
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5) Dressing Response to In-vitro Model Wound Biofilms
In-vitro colony wound biofilms, produced from burn wound pathogens, S. aureus
and P. aeruginosa, and control E. coli were grown for 24, 48 and 72 hours and
tested with prototype dressings (figure 6a). Within 5 hours of incubation with
biofilms, the fluorescent response was clearly observed in dressings (figure 6b).
Figure 6. Fluorescent response of prototype dressing to in-vitro model wound biofilms (a) time dependent response of dressings 
with 24 hour biofilms, and (b) photograph of dressings with biofilms taken under UV (254 nm) light.
6) Ex-vivo Porcine Burn Wound Model and Dressing Response
Using organic porcine skins, ex-vivo burn wound, as a more realistic model, was
further developed for the evaluation of the dressing performance.11 Scaled burns
were created with a hot metal block on disinfected pig skins (figure 7a) and infected
with selected strains of SPE pathogens to establish biofilms allowing only burned
tissues as a sole carbon source for infected bacteria (figure 7b). After 24 hours of
growth at 37°C, each dressing was placed on the burn wounds and incubated up to
24 hours to test the dressing response (figure 7c). Fluorescent response was
observed in all of the dressings except for the control biofilms of E. coli.
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Figure 7. Ex-vivo porcine burn wound model and fluorescent response of prototype dressings (a) scaled burn on a porcine skin, 
(b) 24 hour biofilm of P. aeruginosa, and (c) dressing response to porcine wound biofilms, seen under UV (254 nm) light.
Conclusion
A prototype intelligent wound dressing is developed and the dressing performance
is accessed by testing with in-vitro and ex-vivo porcine wound biofilm models of
clinically important S. aureus, P. aeruginosa and E. faecalis (SPE) pathogens.
Patterned vesicles in hydrogel dressing are lysed by virulence factors of
pathogenic bacteria in model biofilms only and triggered the release of fluorescent
dyes which are visible to naked eyes. This study provides proof-of-concept for an
advanced infection-detecting dressing for wound care, which could allow the
targeted treatment of infections at the bedside and reduce the unnecessary use of
antibiotics.
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